Advertisement

ResearchIn-Press PreviewDermatologyInflammationMetabolism Open Access | 10.1172/jci.insight.192507

DGAT2 reduction and lipid dysregulation drive psoriasis development in keratinocyte-specific SPRY1-deficient mice

Ying-Ying Li,1 Li-Ran Ye,1 Ying-Zhe Cui,1 Fan Xu,1 Xi-Bei Chen,1 Feng-Fei Zhang,1 Yi Lu,1 Yu-Xin Zheng,1 and Xiao-Yong Man1

1Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Find articles by Li, Y. in: PubMed | Google Scholar

1Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Find articles by Ye, L. in: PubMed | Google Scholar

1Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Find articles by Cui, Y. in: PubMed | Google Scholar

1Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Find articles by Xu, F. in: PubMed | Google Scholar |

1Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Find articles by Chen, X. in: PubMed | Google Scholar

1Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Find articles by Zhang, F. in: PubMed | Google Scholar

1Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Find articles by Lu, Y. in: PubMed | Google Scholar

1Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Find articles by Zheng, Y. in: PubMed | Google Scholar

1Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Find articles by Man, X. in: PubMed | Google Scholar

Published July 22, 2025 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.192507.
Copyright © 2025, Li et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published July 22, 2025 - Version history
View PDF
Abstract

Psoriasis is a chronic autoimmune skin disease characterized by abnormal keratinocyte proliferation and immune dysregulation. Altered lipid metabolism has been implicated in its pathogenesis, but the underlying mechanisms remain unclear. In this study, we generated an keratinocyte-specific Sprouty RTK signaling antagonist 1 (SPRY1) knockout (Spry1ΔEpi) mouse model, which exhibits psoriasis-like symptoms. Using both psoriasis patient samples and Spry1ΔEpi mice, we investigated the role of diacylglycerol acyltransferase 2 (DGAT2) in psoriasis. Our results show that DGAT2 expression is reduced, and glycerides metabolism is disrupted in psoriatic lesions in both psoriasis patients and Spry1ΔEpi mice. Lipidomic analysis reveals significant alterations in glycerides, glycerophospholipids, sphingolipids, and fatty acids in Spry1ΔEpi mice. At the cellular level, DGAT2 downregulation and lipid dysregulation enhance Toll-like receptor 3 (TLR3)-mediated inflammatory signaling in keratinocytes. Furthermore, increased DGAT2 secretion from keratinocytes promotes CD8⁺ T cell activation, proliferation and survival, amplifying psoriatic inflammation. These findings highlight the role of DGAT2 and lipid metabolism in the pathogenesis of psoriasis and reveal their interaction with immune responses in psoriasis.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View Revision checklist

View

View proof of Academic licensing from BioRender

Version history
  • Version 1 (July 22, 2025): In-Press Preview
Advertisement
Advertisement